Addison P - Search Results

1

Vitreous relapse following primary chemotherapy for retinoblastoma: is adjuvant diode laser a risk factor?

Gombos DS, Cauchi PA, Hungerford JL, Addison P, Coen PG, Kingston JE. Gombos DS, et al. Among authors: addison p. Br J Ophthalmol. 2006 Sep;90(9):1168-72. doi: 10.1136/bjo.2006.091223. Epub 2006 May 17. Br J Ophthalmol. 2006. PMID: 16707528 Free PMC article.

2

Desegmentation of Ozurdex implant in vitreous cavity: report of two cases.

Agrawal R, Fernandez-Sanz G, Bala S, Addison PK. Agrawal R, et al. Br J Ophthalmol. 2014 Jul;98(7):961-3. doi: 10.1136/bjophthalmol-2014-304866. Epub 2014 Mar 19. Br J Ophthalmol. 2014. PMID: 24648417

3

Predictive factors for treatment failure in patients with presumed ocular tuberculosis in an area of low endemic prevalence.

Agrawal R, Gonzalez-Lopez JJ, Nobre-Cardoso J, Gupta B, Grant R, Addison PK, Westcott M, Pavesio CE. Agrawal R, et al. Br J Ophthalmol. 2016 Mar;100(3):348-55. doi: 10.1136/bjophthalmol-2014-306474. Epub 2015 Jul 17. Br J Ophthalmol. 2016. PMID: 26187952

4

Posterior polar cataract is the predominant consequence of a recurrent mutation in the PITX3 gene.

Addison PK, Berry V, Ionides AC, Francis PJ, Bhattacharya SS, Moore AT. Addison PK, et al. Br J Ophthalmol. 2005 Feb;89(2):138-41. doi: 10.1136/bjo.2004.053413. Br J Ophthalmol. 2005. PMID: 15665340 Free PMC article.

5

Systematic Evaluation of Optical Coherence Tomography Angiography in Retinal Vein Occlusion.

Nobre Cardoso J, Keane PA, Sim DA, Bradley P, Agrawal R, Addison PK, Egan C, Tufail A. Nobre Cardoso J, et al. Among authors: addison pk. Am J Ophthalmol. 2016 Mar;163:93-107.e6. doi: 10.1016/j.ajo.2015.11.025. Epub 2015 Nov 24. Am J Ophthalmol. 2016. PMID: 26621685

6

What does IGRA testing add to the diagnosis of ocular tuberculosis? A Bayesian latent class analysis.

Agrawal R, Grant R, Gupta B, Gunasekeran DV, Gonzalez-Lopez JJ, Addison PKF, Westcott M, Pavesio CE. Agrawal R, et al. BMC Ophthalmol. 2017 Dec 8;17(1):245. doi: 10.1186/s12886-017-0597-x. BMC Ophthalmol. 2017. PMID: 29216851 Free PMC article.

7

Real-Life Evidence for Using a Treat-and-Extend Injection Regime for Patients with Central Retinal Vein Occlusion.

Eleftheriadou M, Nicholson L, D'Alonzo G, Addison PKF. Eleftheriadou M, et al. Ophthalmol Ther. 2019 Jun;8(2):289-296. doi: 10.1007/s40123-019-0184-8. Epub 2019 Apr 10. Ophthalmol Ther. 2019. PMID: 30969404 Free PMC article.

8

Real-World 1-Year Outcomes of Treatment-Intensive Neovascular Age-Related Macular Degeneration Switched to Faricimab.

Sim SY, Chalkiadaki E, Koutsocheras G, Nicholson L, Sivaprasad S, Patel PJ, Selvam S, Pal B, Keane PA, Bhatia B, Hamilton R; Moorfields Medical Retina Injection Service. Sim SY, et al. Ophthalmol Retina. 2025 Jan;9(1):22-30. doi: 10.1016/j.oret.2024.07.020. Epub 2024 Jul 30. Ophthalmol Retina. 2025. PMID: 39084554

9

The role of anti-tubercular therapy in patients with presumed ocular tuberculosis.

Agrawal R, Gupta B, Gonzalez-Lopez JJ, Rahman F, Phatak S, Triantafyllopoulou I, Addison PK, Westcott M, Pavesio CE. Agrawal R, et al. Ocul Immunol Inflamm. 2015 Feb;23(1):40-6. doi: 10.3109/09273948.2014.986584. Ocul Immunol Inflamm. 2015. PMID: 25615809

10

Individualizing Therapy for Neovascular Age-Related Macular Degeneration with Aflibercept (VITAL): A Two-Year Prospective, Interventional Single-Centre Trial.

Patel PJ, Jayaram H, Eleftheriadou M, Vazquez-Alfageme C, Islam N, Rubin GS, Pal B, Addison PK, Hamilton R, Degli Esposti S. Patel PJ, et al. Ophthalmol Ther. 2020 Sep;9(3):563-576. doi: 10.1007/s40123-020-00267-5. Epub 2020 Jun 18. Ophthalmol Ther. 2020. PMID: 32557168 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

178 results

Search Page

Filters